Risk Management Resources Publications

Publications

Publications

Download some fulltext articles (PDF):

  1. Arana A, Arellano FM. Cancer incidence near oilfields in the Amazon basin of Ecuador revisited. Occup. Environ. Med. 2007; 64; 490. Published online in Occupational and Environmental Medicine (OEM) Online. Internet:
    <http://oem.bmj.com/cgi/content/full/64/7/490> [en].
    Accessed: June 29, 2007.

  2. Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernández AM, Goldsmith DI, Jones JK, Moore N, Trenque T, Van Puijenbroek E,  Williams F. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiology and Drug Safety 2007; 16: 581–587. Published online in Wiley InterScience.— Copyright © 2007 Kelly et al.

  3. Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards RI, Fernández AM, Freedman SB, Goldsmith DI, Huang KA, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, Van Puijenbroek E,  Williams F, Wise RP. Guidelines for Submitting Adverse Event Reports for Publication. Drug Safety 2007; 30 (5): 367-373.— © 2007 Adis Data Information BV.

  4. Arellano FM, Wentworth CE, Arana A, Fernández C, Paul CF. Risk of Lymphoma Following Exposure to Calcineurin Inhibitors and Topical Steroids in Patients with Atopic Dermatitis. J Invest Dermatol [Received 16 April 2006; revised 21 September 2006; accepted 22 September 2006].— © 2006 The Society for Investigative Dermatology.

  5. Arellano FM, Ulcickas Yood M, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profiley. Pharmacoepidemiology and Drug Safety 2006; 15: 861–872.— Copyright © 2006 John Wiley & Sons, Ltd.

  6. Arana A, Arellano FM. Cancer incidence near oil fields in the Amazon basin of Ecuador revisited.

  7. Arellano FM. Observational studies and the withdrawal of rofecoxib. Pharmacoepidemiology and Drug Safety 2006; 15: 203–205.— Copyright © 2006 John Wiley & Sons, Ltd.

  8. Arellano FM. The withdrawal of rofecoxib (editorial). Pharmacoepidemiology and Drug Safety 2005; 14: 213–217.— Copyright © 2006 John Wiley & Sons, Ltd.

  9. Rothman KJ, Young-Xu Y, Arellano FM. Age Dependence of the Relation between Reassortant Rotavirus Vaccine (RotaShield) and Intussusception (correspondence). J Invest Dermatol 2006; 193 (15 March): 898.

  10. Walker AM, Lanza LL, Arellano FM, Rothman KJ. Mortality in Current and Former Users of Clozapine. Epidemiology 1997; 8:6 (November): 671-677.— © 1997 by Epidemiology Resources Inc.

  11. Arellano FM, Castellsague J. (Unlearned) Lessons from John Graunt and Kenneth Rothman: A “CLASSic” Example (commentary). Clinical Therapeutics 2003; 25:11: 2891-2896.— Copyright © 2003 Excerpta Medica, Inc.

  12. Rothman KJ, Arellano FM. Elevating the level of scientific discourse (letters). IJOEH 2005; 11:2 (Apr/Jun): 327-328.— © INT J OCCUP ENVIRON HEALTH.

  13. Arana A, Varas C, González-Pérez A, Gutiérrez L, Bjerrum L, García Rodríguez LA. Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause: The Journal of The North American Menopause Society 2006; 13:5: 1-7.— © 2006 by The North American Menopause Society.

  14. Sánchez-Matienzo D, Arana A, Castellsague J, Pérez-Gutthann S. Hepatic Disorders in Patients Treated with COX-2 Selective Inhibitors or Nonselective NSAIDs: A Case/Noncase Analysis of Spontaneous Reports. Clinical Therapeutics 2006; 28:8 (August): 1123-1132.— Copyright © 2003 Excerpta Medica, Inc.

  15. Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12760 Clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry 1999; 175: 576-580.

go to Home
go to About Us
go to Databases
go to Epidemiology
go to Pharmacovigilance
go to Research & Development
go to Services
go to Publications
go to Contact
go to Related Links
Copyright © 2006— Risk Management Resources. All Rights Reserved.
All trademarks and brands are property of their respective owners.
See our Legal Notice. Use of this web site constitutes acceptance of the Terms of Use and Privacy Policy.